Tumor response in primary kidney lesions and metastatic lesions in nivolumab plus ipilimumab therapy for advanced renal cell carcinoma without prior nephrectomy: Preliminary results of a multi‐institutional study
Abstract
Toshio Takagi and Tsunenori Kondo received honoraria from Bristol Myers Squibb and Ono Pharmaceutical. The other authors declare no conflict of interest. Table S1. Patient characteristics. Table S2. Profile of immune-related adverse reactions. Table S3. Tumor response across lesions. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than...
Paper Details
Title
Tumor response in primary kidney lesions and metastatic lesions in nivolumab plus ipilimumab therapy for advanced renal cell carcinoma without prior nephrectomy: Preliminary results of a multi‐institutional study
Published Date
Jul 3, 2021
Volume
28
Issue
10
Pages
1075 - 1076
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History